REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S (Colombia)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Ambulatory Health Care Services
Full name: Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S Profile Updated: April 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S is based in Colombia. The head office is in Santa Marta. It operates in the General Medical and Surgical Hospitals industry. It was incorporated on July 13, 2006. From the latest financial highlights, Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S reported a net sales revenue drop of 37.76% in 2025. A growth of 49.25% was recorded in its total assets. The net profit margin of Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S increased by 7.16% in 2025.

Headquarters
Cr 15 24 37
Santa Marta; Magdalena;

Contact Details: Purchase the Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S report to view the information.

Basic Information
Registered Capital:
Purchase the Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S report to view the information.
Financial Auditors:
Purchase the Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S report to view the information.
Incorporation Date:
July 13, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad Hemato-Oncologica Y De Radioterapia Del Caribe S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-37.76%
Total Operating Revenue
-37.76%
Operating Profit
-66.65%
EBITDA
-66.65%
Net Profit/Loss for the Period
29.88%
Total Assets
49.25%
Total Equity
74.9%
Operating Profit Margin
-11.9%
Net Profit Margin
7.16%
Return on Equity (ROE)
-4.38%
Quick Ratio
0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?